IPSEN BIOPHARMACEUTICALS
Live / Registered — Registered — Section 8 accepted (as of 17 Aug 2023)
What this means for you
Registered since 28 Mar 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 85519918
- Registration number
- 5171734
- Mark type
- Stylized text
- Filed
- 19 Jan 2012
- Published for opposition
- 16 Oct 2012
- Registered
- 28 Mar 2017
- Attorney of record
- Ben Natter
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology, endocrinology, neurology, hematology, gastroenterology, and for cardiovascular and cognitive disorders; pharmaceutical preparations for use in urology, pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations for the treatment and prevention of neuromuscular disorders; pharmaceutical preparations for the treatment and prevention of cervical dystonia, cerebral palsy, and spasticity
Owner
- IPSEN S.A., Paris, FR
- IPSEN S.A., Boulogne Billancourt, FR
- IPSEN S.A., Boulogne Billancourt, FR
Prior registrations
Prosecution history
- 28 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 29 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Aug 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 23 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Aug 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Aug 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Aug 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 17 Aug 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 17 Aug 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Mar 2023 — TEAS SECTION 8 RECEIVED
- 28 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED